Leading the Way in Life Science Technologies

GEN Exclusives

More »
Insight & Intelligence™

Related to EMA Says Benefits of Celgene’s Myeloma Drug Outweigh Risks Despite Increased Incidence of New Cancers

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »